Sub-lethal light dose at 405 nm caused morphological changes on bacterial surface indicating the cell wall as one of the main targets of photodamage
[link] A Bucksch, A Atta-Boateng, A F Azihou, D Battogtokh, A Baumgartner, B M Binder, S Braybrook, C Chang, V Coneva, T DeWitt, A Fletcher, M Gehan, D H Diaz Martinez, L Hong, A Iyer-Pascuzzi, LL Klein, S A Leiboff, M Li, J Lynch, A Maizel, J N Maloof, RJ C Markelz, C Martinez, L A Miller, W Mio, W Palubicki, H Poorter, C Pradal, C Price, E Puttonen, J Reese, R Rellan-Alvarez, E P Spalding, E E
*Please note that the Mid-Point Assessment was based on the PPS efforts through the DY2, Q1 PPS Quarterly Report to accommodate the timelines necessary to ensure the completion of all Mid-Point Assessment tasks prior to the start of DY3
Information Does not contain potential allergens such as sugar, starch, salt, yeast, gluten, soy, corn and dairy products
This surge may be attributed to the FDA mandating manufacturers of incretin-based medications to revise their product labels in 2009, providing information regarding the potential risk of pancreatitis (Nelson et al., 2014)